The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Inhibition of Hypoxia-inducible Factor (HIF) Hydroxylases by Citric Acid Cycle Intermediates
Open accessAbstract
The stability and transcriptional activity of the hypoxia-inducible factors (HIFs) are regulated by two oxygen-dependent events that are catalyzed by three HIF prolyl 4-hydroxylases (HIF-P4Hs) and one HIF asparaginyl hydroxylase (FIH). We have studied possible links between metabolic pathways and HIF hydroxylases by analyzing the abilities of citric acid cycle intermediates to inhibit purified human HIF-P4Hs and FIH. Fumarate and succinate were identified as in vitro inhibitors of all three HIF-P4Hs, fumarate having K(i) values of 50-80 microM and succinate 350-460 microM, whereas neither inhibited FIH. Oxaloacetate was an additional inhibitor of all three HIF-P4Hs with K(i) values of 400-1000 microM and citrate of HIF-P4H-3, citrate being the most effective inhibitor of FIH with a K(i) of 110 microM. Culturing of cells with fumarate diethyl or dimethyl ester, or a high concentration of monoethyl ester, stabilized HIF-1alpha and increased production of vascular endothelial growth factor and erythropoietin. Similar, although much smaller, changes were found in cultured fibroblasts from a patient with fumarate hydratase (FH) deficiency and upon silencing FH using small interfering RNA. No such effects were seen upon culturing of cells with succinate diethyl or dimethyl ester. As FIH was not inhibited by fumarate, our data indicate that the transcriptional activity of HIF is quite high even when binding of the coactivator p300 is prevented. Our data also support recent suggestions that the increased fumarate and succinate levels present in the FH and succinate dehydrogenase-deficient tumors, respectively, can inhibit the HIF-P4Hs with consequent stabilization of HIF-alphas and effects on tumor pathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Loss-of-function mutations in SDH and FH cause a build-up of succinate and fumarate, respectively87. Accordingly, increased levels of succinate and fumarate caused by mutations in these genes can compete with αKG and inhibit activity of HIF hydroxylases and thus induce normoxic HIF1α activity in vitro88,89.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [89]
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., & Bruick, R. K. (2002) · Genes & Development · doi:10.1101/gad.991402 · Cited by 1,550
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 516
Citric Acid Cycle Intermediates in Cardioprotection
Czibik, G., Steeples, V., Yavari, A., & Ashrafian, H. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000220 · Cited by 58
Extended Ischemia Prevents HIF1α Degradation at Reoxygenation by Impairing Prolyl-hydroxylation
Serra‐Pérez, A., Planas, A. M., Núñez-O’Mara, A., Berra, E., García‐Villoria, J., Ribes, A., & Santalucı́a, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.101048 · Cited by 55
Involvement of Tricarboxylic Acid Cycle Metabolites in Kidney Diseases
Jiménez‐Uribe, A. P., Cruz, E. Y. H., Ramírez-Magaña, K. J., & Pedraza‐Chaverrí, J. (2021) · Biomolecules · doi:10.3390/biom11091259 · Cited by 56
HIF-1α and HIF-2α Differently Regulate the Radiation Sensitivity of NSCLC Cells
Roig, E. M., Groot, A. J., Yaromina, A., Hendrickx, T. C., Barbeau, L. M. O., Giuranno, L., Dams, G., Ient, J., Pimentel, V. O., van Gisbergen, M. W., et al. (2019) · Cells · doi:10.3390/cells8010045 · Cited by 56
Structural basis for malfunction in complex II
Iverson, T. M., Maklashina, E., & Cecchini, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.408419 · Cited by 53
Macrophages harness hepatocyte glutamate to boost liver regeneration
Rigual, M. D. M., Angulo-Aguado, M., Zagorac, S., Álvarez-Díaz, R., Benítez-Mondéjar, M., Yi, F., Martínez-Garay, C., Santos-de-Frutos, K., Kim, E., Campos-Olivas, R., et al. (2025) · Nature · doi:10.1038/s41586-025-08778-6 · Cited by 53
Succinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and Epigenetics
Her, Y. F., & Maher, L. J. (2015) · International Journal of Endocrinology · doi:10.1155/2015/296167 · Cited by 53
l-glutamine is a key parameter in the immunosuppression phenomenon
Hammami, I., Chen, J., Bronte, V., Crescenzo, G. D., & Jolicœur, M. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.139 · Cited by 53
Metabolomics of AS ‐5 RBC supernatants following routine storage
D’Alessandro, A., Hansen, K. C., Silliman, C. C., Moore, E. E., Kelher, M. R., & Banerjee, A. M. (2014) · Vox Sanguinis · doi:10.1111/vox.12193 · Cited by 53
α-Ketoglutarate abrogates the nuclear localization of HIF-1α in aluminum-exposed hepatocytes
Mailloux, R. J., Puiseux‐Dao, S., & Appanna, V. D. (2008) · Biochimie · doi:10.1016/j.biochi.2008.10.014 · Cited by 53
Gaster, M., Nehlin, J. O., & Minet, A. D. (2012) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2012.656653 · Cited by 55
HIF1, HSF1, and NRF2: Oxidant-Responsive Trio Raising Cellular Defenses and Engaging Immune System
Cyran, A. M., & Zhitkovich, A. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00131 · Cited by 55
Transplantation of prokaryotic two-component signaling pathways into mammalian cells
Hansen, J., Mailand, E., Swaminathan, K. K., Schreiber, J., Angelici, B., & Benenson, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406482111 · Cited by 52
Apaydin, I., Konaç, E., Önen, H. İ., Akbaba, M., Tekin, E., & Ekmekçi, A. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.11.012 · Cited by 52
Park, Y.-K., Ahn, D., Oh, M., Tae-Kyoung, L., Yang, E. G., Son, M., & Park, H. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045278 · Cited by 52
The role of PHD2 mutations in the pathogenesis of erythrocytosis
Gardie, B., Percy, M. J., Hoogewijs, D., Chowdhury, R., Bento, C., McMullin, M. F., Schofield, C. J., Lee, F. S., Richard, S., Arsenault, P. R., et al. (2014) · Hypoxia · doi:10.2147/hp.s54455 · Cited by 53
Houston, M. A., Augenlicht, L. H., & Heerdt, B. G. (2011) · International Journal of Cell Biology · doi:10.1155/2011/978583 · Cited by 50
Altered Hypoxic–Adenosine Axis and Metabolism in Group III Pulmonary Hypertension
Garcia‐Morales, L. J., Chen, N., Weng, T., Luo, F., Davies, J., Philip, K., Volcik, K. A., Melicoff, E., Amione‐Guerra, J., Bunge, R. R., et al. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0145oc · Cited by 52
Fumarate Hydratase Deficiency and Cancer: Activation of Hypoxia Signaling?
Ratcliffe, P. J. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.03.015 · Cited by 50
Marden, J. H., Fescemyer, H. W., Schilder, R. J., Doerfler, W. R., Vera, J. C., & Wheat, C. W. (2012) · Evolution · doi:10.1111/evo.12004 · Cited by 49
Bharadwaj, S., Singh, M. V., Kirtipal, N., & Kang, S. G. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.627842 · Cited by 50
Functional implications of fumarate-induced cysteine succination
Guberović, I., & Frezza, C. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.05.003 · Cited by 52
Sensitivity of hematopoietic stem cells to mitochondrial dysfunction by SdhD gene deletion
Bejarano-García, J. A., Millán‐Uclés, Á., Rosado, I. V., Sánchez‐Abarca, L. I., Caballero‐Velázquez, T., Durán-Galván, M. J., Pérez‐Simón, J. A., & Piruat, J. I. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.411 · Cited by 54
Dynamic regulation of epigenetic demethylation by oxygen availability and cellular redox
Lamadema, N., Burr, S., & Brewer, A. C. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.12.009 · Cited by 50
Deregulation of E2-EPF Ubiquitin Carrier Protein in Papillary Renal Cell Carcinoma
Roos, F. C., Evans, A. J., Brenner, W., Wondergem, B., Klomp, J., Heir, P., Roche, O., Thomas, C., Schimmel, H., Furge, K. A., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.10.033 · Cited by 48
Hypoxia Inducible Factor-1α in Osteochondral Tissue Engineering
Taheem, D. K., Jell, G., & Gentleman, E. (2019) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2019.0283 · Cited by 47
Mitochondrial Regulation of Macrophage Response Against Pathogens
Choudhuri, S., Chowdhury, I. H., & Garg, N. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.622602 · Cited by 49
Progress of stimulus responsive nanosystems for targeting treatment of bacterial infectious diseases
Yang, N., Sun, M., Wang, H., Hu, D., Zhang, A., Khan, S., Chen, Z., Chen, D., & Xie, S. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103078 · Cited by 47
Stubbs, C. J., Loenarz, C., Mecinović, J., Yeoh, K. K., Hindley, N., Liénard, B. M. R., Sobott, F., Schofield, C. J., & Flashman, E. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900285r · Cited by 46
Fumaric Acid Esters Stimulate Astrocytic VEGF Expression through HIF-1α and Nrf2
Wiesner, D., Merdian, I., Lewerenz, J., Ludolph, A. C., Dupuis, L., & Witting, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076670 · Cited by 45
Tarhonskaya, H., Nowak, R. P., Johansson, C., Szykowska, A., Tumber, A., Hancock, R. L., Lang, P. A., Flashman, E., Oppermann, U. C. T., Schofield, C. J., et al. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.08.007 · Cited by 45
Garcia-Rojas, E. Y. L., Villanueva, C., & Bond, R. A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.709509 · Cited by 49
Sinton, M. C., Hay, D. C., & Drake, A. J. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0702-5 · Cited by 44
Muscle-Liver Substrate Fluxes in Exercising Humans and Potential Effects on Hepatic Metabolism
Hu, C., Hoene, M., Plomgaard, P., Hansen, J. S., Zhao, X., Li, J., Wang, X., Clemmesen, J. O., Secher, N. H., Häring, H. U., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz266 · Cited by 44
Xu, Y., Brown, K. M., Wang, Z. A., van der Wel, H., Teygong, C., Zhang, D., Blader, I. J., & West, C. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.355446 · Cited by 44
Goffaux, G., Hammami, I., & Jolicœur, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-10464-1 · Cited by 47
Millonig, G., Hegedüsch, S., Becker, L. S., Seitz, H. K., Schuppan, D., & Mueller, S. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.043 · Cited by 43
The Asparagine Hydroxylase FIH: A Unique Oxygen Sensor
Volkova, Y. L., Pickel, C., Jucht, A. E., Wenger, R. H., & Scholz, C. C. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0003 · Cited by 43
Lin-Holderer, J., Li, L., Gruneberg, D., Marti, H. H., & Kunze, R. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.023 · Cited by 44
Hypoxia and aerobic metabolism adaptations of human endothelial cells
Kozieł, A., & Jarmuszkiewicz, W. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1935-9 · Cited by 42
Culp‐Hill, R., Srinivasan, A. J., Gehrke, S. A., Kamyszek, R. W., Ansari, A. K., Shah, N., Welsby, I. J., & D’Alessandro, A. (2018) · Transfusion · doi:10.1111/trf.14931 · Cited by 43
Bailey, P. S. J., & Nathan, J. A. (2018) · Biomedicines · doi:10.3390/biomedicines6020060 · Cited by 41
Hart, P. C., Kenny, H. A., Graßl, N., Watters, K. M., Litchfield, L. M., Coscia, F., Blaženović, I., Ploetzky, L., Fiehn, O., Mann, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.079 · Cited by 41
Succinate Dehydrogenase Upregulation Destabilize Complex I and Limits the Lifespan of gas-1 Mutant
Pujol, C., Hench, I. B., Sumakovic, M., Hench, J., Mourier, A., Baumann, L. C., Pavlenko, V., & Trifunović, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059493 · Cited by 40
Hypoxia-inducible factors and the prevention of acute organ injury
Heyman, S. N., Rosen, S., & Rosenberger, C. (2011) · Critical Care · doi:10.1186/cc9991 · Cited by 42
Emerging role of glycosylation in the polarization of tumor-associated macrophages
Mantuano, N. R., Oliveira-Nunes, M. C., Alisson‐Silva, F., Dias, W. B., & Todeschini, A. R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104285 · Cited by 40
Peurala, E., Koivunen, P., Bloigu, R., Haapasaari, K., & Jukkola‐Vuorinen, A. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1750-5 · Cited by 39
Self-citationStunted by Developing in Hypoxia: Linking Comparative and Model Organism Studies
Harrison, J. F., Shingleton, A. W., & Callier, V. (2015) · Physiological and Biochemical Zoology · doi:10.1086/682216 · Cited by 40
Ferro, A., Carbone, E. A., Zhang, J., Marzouk, E., Villegas, M. A. F., Siegel, A., Nguyen, D., Possidente, T., Hartman, J., Polley, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188425 · Cited by 39
Bosello-Travain, V., Forman, H. J., Roveri, A., Toppo, S., Ursini, F., Venerando, R., Warnecke, C., Zaccarin, M., & Maiorino, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.12.020 · Cited by 38
Flagg, S. C., Martin, C. B., Taabazuing, C. Y., Holmes, B. E., & Knapp, M. J. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.03.002 · Cited by 38
Oxidative Phosphorylation as a Target to Arrest Malignant Neoplasias
Rodríguez‐Enríquez, S., Gallardo‐Pérez, J. C., Marín‐Hernández, Á., Aguilar-Ponce, J. L., Mandujano-Tinoco, E. A., Meneses, A., & Moreno‐Sánchez, R. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796391561 · Cited by 37
Normoxic accumulation of HIF1α is associated with glutaminolysis
Kappler, M., Pabst, U., Rot, S., Taubert, H. W., Wichmann, H., Schubert, J., Bache, M., Weinholdt, C., Immel, U., Große, I., et al. (2016) · Clinical Oral Investigations · doi:10.1007/s00784-016-1780-9 · Cited by 38
Pappalardi, M. B., McNulty, D. E., Martin, J. D., Fisher, K. E., Jiang, Y., Burns, M. C., Zhao, H., Ho, T. F., Sweitzer, S. M., Schwartz, B., et al. (2011) · Biochemical Journal · doi:10.1042/bj20101201 · Cited by 38
Prolyl hydroxylase domain enzymes and their role in cell signaling and cancer metabolism
Nguyen, T.-L., & Durán, R. V. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.09.026 · Cited by 40
2-Oxoglutarate derivatives can selectively enhance or inhibit the activity of human oxygenases
Nakashima, Y., Brewitz, L., Tumber, A., Salah, E., & Schofield, C. J. (2021) · Nature Communications · doi:10.1038/s41467-021-26673-2 · Cited by 38
Mechanisms of tumor promotion by reactive oxygen species
Kobliakov, V. A. (2010) · Biochemistry (Moscow) · doi:10.1134/s0006297910060015 · Cited by 37
The real face of HIF1α in the tumor process
Kappler, M., Taubert, H. W., Schubert, J., Vordermark, D., & Eckert, A. W. (2012) · Cell Cycle · doi:10.4161/cc.21854 · Cited by 38
Regulated Function of the Prolyl-4-Hydroxylase Domain (PHD) Oxygen Sensor Proteins
Nytko, K. J., Spielmann, P., Camenisch, G., Wenger, R. H., & Stiehl, D. P. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1683 · Cited by 37
Three autocrine feedback loops determine HIF1α expression in chronic hypoxia
Qutub, A. A., & Popel, A. S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.07.004 · Cited by 37
Gharib, E., Veilleux, V., Boudreau, L. H., Pichaud, N., & Robichaud, G. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1207631 · Cited by 37
MicroRNA regulation of cancer metabolism: role in tumour suppression
Tomasetti, M., Santarelli, L., Neužil, J., & Dong, L. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.06.004 · Cited by 36
Oxaloacetate induces apoptosis in HepG2 cells via inhibition of glycolysis
Kuang, Y., Han, X., Xu, M., & Yang, Q. (2018) · Cancer Medicine · doi:10.1002/cam4.1410 · Cited by 35
van Gijsel‐Bonnello, M., Baranger, K., Benech, P., Rivera, S., Khrestchatisky, M., Reggi, M. L. D., & Gharib, B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194586 · Cited by 35
Regulation of Vascular and Renal Function by Metabolite Receptors
Peti‐Peterdi, J., Kishore, B. K., & Pluznick, J. L. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105403 · Cited by 34
Brewitz, L., Tumber, A., & Schofield, C. J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012202 · Cited by 34
Vohwinkel, C. U., Coit, E. J., Burns, N., Elajaili, H. B., Hernández-Saavedra, D., Yuan, X., Eckle, T. D. L. G., Nozik‐Grayck, E., Tuder, R. M., & Eltzschig, H. K. (2021) · The FASEB Journal · doi:10.1096/fj.202002778r · Cited by 35
Macklin, P. S., Yamamoto, A., Browning, L., Hofer, M., Adam, J., & Pugh, C. W. (2020) · The Journal of Pathology · doi:10.1002/path.5402 · Cited by 33
Mitochondria and the permeability transition pore in cancer metabolic reprogramming
Guo, L. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114537 · Cited by 34
Succinate receptor 1 inhibits mitochondrial respiration in cancer cells addicted to glutamine
Rabe, P., Liebing, A., Krumbholz, P., Kraft, R., & Stäubert, C. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.11.024 · Cited by 33
Zuk, A., Si, Z., Loi, S., Bommegowda, S., Hoivik, D. J., Danthi, S. J., Molnar, G., Csizmadia, V., & Rabinowitz, M. H. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001126 · Cited by 34
Prandota, J. (2010) · Research in Autism · doi:10.1016/j.rasd.2010.03.009 · Cited by 34
Robust metabolic adaptation underlying tumor progression
Vizán, P., Mazurek, S., & Cascante, M. (2008) · Metabolomics · doi:10.1007/s11306-007-0101-3 · Cited by 35
Kondrashova, M. N., Zakharchenko, M. V., & Khunderyakova, N. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.04.020 · Cited by 33
Mito-Nuclear Communication in Hepatocellular Carcinoma Metabolic Rewiring
Mello, T., Simeone, I., & Galli, A. (2019) · Cells · doi:10.3390/cells8050417 · Cited by 34
Luo, H., Wang, Q., Yang, F., Liu, R. R., Gao, Q., Cheng, B., Lin, X., Huang, L., Chen, C., Jin, X., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.164968 · Cited by 39
Oxygen Concentration Controls Epigenetic Effects in Models of Familial Paraganglioma
Her, Y. F., Nelson-Holte, M. H., & Maher, L. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127471 · Cited by 34
The PHD1 oxygen sensor in health and disease
Kennel, K. B., Burmeister, J., Schneider, M. A., & Taylor, C. T. (2018) · The Journal of Physiology · doi:10.1113/jp275327 · Cited by 34
Schlisio, S. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00881.x · Cited by 33
Metabolic control of renin secretion
Peti‐Peterdi, J., Gevorgyan, H. A., Lam, L., & Riquier‐Brison, A. (2012) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1130-y · Cited by 32
Endothelial FUNDC1 Deficiency Drives Pulmonary Hypertension
Pei, Y., Ren, D., Yin, Y., Shi, J., Ai, Q., Hao, W., Luo, X., Zhang, C., Zhao, Y., Bai, C., et al. (2024) · Circulation Research · doi:10.1161/circresaha.124.325156 · Cited by 31
Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells
Xiao, H., LI, S., Zhang, D., Liu, T., Yu, M., & Wang, F. (2012) · Oncology Reports · doi:10.3892/or.2012.2085 · Cited by 31
Glutamine, Glucose and other Fuels for Cancer
Ruiz-Pérez, M. V., Sánchez‐Jiménez, F., Alonso, F. J., Segura, J., Márquez, J., & Medina, M. Á. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990482 · Cited by 31
Grigolon, R. B., Gerchman, F., Schöffel, A. C., Hawken, E. R., Gill, H., Vázquez, G. H., Mansur, R. B., McIntyre, R. S., & Brietzke, E. M. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109947 · Cited by 32
Inhibition of AlkB Nucleic Acid Demethylases: Promising New Epigenetic Targets
Perry, G. S., Das, M., & Woon, E. C. Y. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01694 · Cited by 32
Campione, E., Mazzilli, S., Prete, M. D., Dattola, A., Cosio, T., Lettieri‐Barbato, D., Costanza, G., Lanna, C., Manfreda, V., Shumak, R. G., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.760852 · Cited by 33
Hypoxia-inducible factor prolyl 4-hydroxylase inhibition in cardiometabolic diseases
Koivunen, P., Serpi, R., & Dimova, E. Y. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.003 · Cited by 33
Self-citationSimón, L., Arazo-Rusindo, M. C., Quest, A. F. G., & Mariotti‐Celis, M. S. (2023) · Antioxidants · doi:10.3390/antiox12091734 · Cited by 31
Trichonas, G., Lee, T. J., Hoppe, G., Au, J. D., & Sears, J. E. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12171 · Cited by 31
Models of parent-of-origin tumorigenesis in hereditary paraganglioma
Hoekstra, A. S., Devilee, P., & Bayley, J. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.05.011 · Cited by 30
Schultz, K., Murthy, V., Tatro, J. B., & Beasley, D. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90393.2008 · Cited by 32
Tiwari, R., Sharma, R., Rajendran, G., Borkowski, G. S., An, S. Y., Schonfeld, M. P., O’Sullivan, J., Schipma, M. J., Zhou, Y., Courbon, G., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci176207 · Cited by 35
Redox imbalance and hypoxia‐inducible factors: a multifaceted crosstalk
Ravi, R., & Singh, J. (2025) · FEBS Journal · doi:10.1111/febs.70013 · Cited by 29
Differential metabolic consequences of fumarate hydratase and respiratory chain defects
Raimundo, N., Ahtinen, J., Fumić, K., Barić, I., Remes, A. M., Renkonen, R., Lapatto, R., & Suomalainen, A. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.008 · Cited by 30
Self-citationde Oliveira, A. B. B., de Moraes, F. R., Cândido, N. M., Sampaio, I., Paula, A. S., de Vasconcellos, A., Silva, T. C., Miller, A. H., Rahal, P., Nery, J. G., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00411 · Cited by 29
Role of HIF in fish inflammation
Shi, X., Gao, F., Zhao, X., Pei, C., Zhu, L., Zhang, J., Li, C., Li, L., & Kong, X. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.109222 · Cited by 28
Chen, W., Liu, R., Zhu, X., Lu, Q., Yang, H., & Liu, R. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250027 · Cited by 30
The known and new ideas about the mechanism of action and the spectrum of effects of Mexidol
Воронина, Т. А., Литвинова, С. А., Гладышева, Н. А., & Вадимович, Ш. А. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202512505122 · Cited by 28
Loss of SDHB Induces a Metabolic Switch in the hPheo1 Cell Line toward Enhanced OXPHOS
Tabebi, M., Dutta, R. K., Skoglund, C., Söderkvist, P., & Gimm, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010560 · Cited by 27
Ting, K. K. Y., Yu, P., Dow, R., Floro, E. J., Ibrahim, H. M., Scipione, C. A., Hyduk, S. J., Polenz, C. K., Zaslaver, O., Karmaus, P. W. F., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300293 · Cited by 27
Metadata
- Authors
- Koivunen, P., Hirsilä, M., Remes, A. M., Hassinen, I. E., Kivirikko, K. I., & Myllyharju, J.
- Affiliations
- University of Oulu (FI)
- Corresponding author
- Myllyharju, Johanna
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 282
- Issue
- 7
- Pages
- 4524-4532
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2004183689
- Semantic Scholar
- c3ddd6b07c5b433f324955c53930fb199e6ecc2a
- Cited by
- 521
- References
- 43
- Citations by year
- 2026: 15 · 2025: 17 · 2024: 23 · 2023: 23 · 2022: 23 · 2021: 39 · 2020: 25 · 2019: 38 · 2018: 25 · 2017: 28 · 2016: 29 · 2015: 33 · 2014: 29 · 2013: 36 · 2012: 32
- FWCI
- 7.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Keywords
- hypoxia-inducible factor, FIH, citric acid cycle intermediates, fumarate, succinic acid, oxaloacetate, citrate, fumarate hydratase deficiency, succinate dehydrogenase deficiency, HIF-1α stabilization, vascular endothelial growth factor, erythropoietin, p300 coactivator, cancer metabolism
- MeSH terms
- Cell Line, Citric Acid Cycle, Dose-Response Relationship, Drug, Enzyme Inhibitors, Erythropoietin, Fibroblasts, Fumarate Hydratase, Mixed Function Oxygenases, Neoplasms, Procollagen-Proline Dioxygenase, Succinate Dehydrogenase, Transcription, Genetic, Gene Expression Regulation, Enzymologic, Vascular Endothelial Growth Factor A, p300-CBP Transcription Factors, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review